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SVPZF is a mutant of Sindbis virus (SV) which we selected on the basis of its ability to replicate in mosquito cells treated
with pyrazofurin (PZF), a drug which inhibits pyrimidine nucleotide biosynthesis (Lin et al., 2000, Virology 272, 61–71). Three
mutations, A6627U, A7543U, and C7593A, were identified in the nsP4 (the viral RNA polymerase) coding region, which were
required for the PZF-resistant phenotype. We report here that SVPZF has a second phenotype. Its replication in BHK cells is
severely restricted; yields of SVPZF from BHK cells are 100- to 1000-fold lower than the yields of standard SV (SVSTD). However,
addition of adenosine to the SVPZF-infected cultures completely relieves this restriction and results in yields comparable to
those observed with SVSTD. Adenosine has no effect on the yield of SVSTD from BHK cells. Synthesis of the viral structural
proteins is markedly depressed in SVPZF-infected BHK cells, as is synthesis of the viral subgenomic (SG) RNA from which
these proteins are translated. In contrast, normal amounts of genomic RNA are made. Experiments with mutagenized viruses
indicated that the SVPZF mutation, C7593A, by itself, was sufficient to produce the restriction phenotype. However, this
mutation not only changes Pro 609 of nsP4 to Thr, it also changes the nucleotide at the 25 position of the SG promoter. To
evaluate the relative contributions of the change in nsP4 and the change in the SG promoter to the restriction phenotype, we
made use of double SG viruses, in which nsP4 and the promoter for the SG RNA which encodes the structural proteins can
be changed independent of each other. Our results indicated that both the change in nsP4 and the change in the SG promoter
were required to produce the full restriction phenotype. We suggest that the changes in nsP4 and the SG promoter
destabilize the RNA initiation complex assembled at the SG promoter and that since ATP is the initiating nucleotide in the SG
RNA transcript, the increased level of ATP resulting from the addition of adenosine is able to compensate for this
destabilization and restore the synthesis of SG RNA to normal levels. © 2002 Elsevier ScienceINTRODUCTION
Sindbis virus (SV) is the prototype virus of the family
Togaviridae, genus Alphavirus. The 11,703 nt-long, posi-
tive-sense, single-stranded RNA genome is capped at its
59 end and polyadenylated at its 39 end. The 59 two-thirds
of the genomic RNA encodes four nonstructural proteins.
The three structural proteins (the capsid protein, C, and
the two envelope proteins, E1 and E2) are translated
from a subgenomic RNA, which is transcribed from an
internal subgenomic (SG) promoter on the full-length,
negative-strand RNA (reviewed in Strauss and Strauss,
1994). The minimal sequence which has promoter activ-
ity extends from nt 219 to nt 15, where the SG transcript
begins at nt 11 (Hertz and Huang, 1992; Levis et al.,
1990).
The four nonstructural proteins, nsP1, nsP2, nsP3, and
nsP4, are derived by the processing of two polyproteins,
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78P123 and P1234. The synthesis of negative-strand and
positive-strand genomic RNA and the transcription of the
subgenomic RNA are regulated temporally by the pro-
cessing of the nonstructural polyproteins (Lemm et al.,
1994, 1998; Sawicki and Sawicki, 1998). Thus, once the
cleavage between the nsP2 and the nsP3 proteins takes
place, the synthesis of negative-strand RNA ceases and
the synthesis of the positive-strand genomic and sub-
genomic RNA becomes more efficient. As to the func-
tions of the nonstructural proteins, nsP1 has both RNA
methyltransferase (Mi et al., 1989; Mi and Stollar, 1990)
and RNA guanylyltransferase activities (Ahola and Ka¨a¨ri-
a¨ianen, 1995; Scheidel et al., 1987). Thus, nsP1 is in-
volved in the modification of the 59 ends of the positive-
strand genomic and subgenomic RNAs. nsP2 is a multi-
functional protein. Its N-terminal domain has an RNA
helicase activity, which may unwind the replicative RNAs
during replication (Gomez et al., 1999). Recently, an RNA
triphosphatase activity has also been associated with
this domain; thus nsP2 appears to also be involved in the
capping of the viral RNA along with nsP1 (Vasiljeva et al.,
2000). The C-terminal domain of nsP2 is a papain-like
protease, which is responsible for the processing of the
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Strauss, 1989). nsP3 is the only one of the nonstructural
proteins which is phosphorylated (Peranen et al., 1988; Li
et al., 1990) but its biochemical function is still unknown.
nsP4 has been identified as the viral RNA polymerase
since it contains the consensus GDD sequence found in
nearly all RNA-dependent RNA polymerases (RDRP) (Ka-
mer and Argos, 1984). Experiments with a ts mutant, ts-6,
in which the mutation lies in the nsP4-coding region, also
point to nsP4 as the viral RNA polymerase (Barton et al.,
1988).
Alphaviruses have an extremely broad host range. In
their natural ecosystem, they are maintained by a man-
datory vertebrate–mosquito–vertebrate transmission cy-
cle. In order to successfully replicate in such different
hosts, the viral proteins involved in virus assembly and
viral RNA synthesis must be able to function efficiently in
host cells that are widely separated phylogenetically. In
the laboratory, however, it is possible to obtain host
range mutants of Sindbis virus which replicate well in
one host cell but are restricted in a different cell type.
Thus, viral mutants with mutations in the E2 coding
sequence have been described which replicate well in
mosquito cells but are restricted in chicken embryonic
fibroblasts (CEF) and baby hamster kidney (BHK) cells (Li
et al., 1999; Durbin and Stollar, 1984). Another Sindbis
virus mutant has been described that does not cleave
PE2 to E2 and is restricted in mosquito cells but not in
vertebrate cells (Boehme et al., 2000).
The structure or amount of nsP4 also appears to in-
fluence the host range of Sindbis virus. Three different
mutations, which mapped to the N-terminus of nsP4,
when introduced into a wild-type background led to a
restriction of replication in mosquito cells but not in BHK
cells (Kowal and Stollar, 1981; Lemm et al., 1990).
Finally, for reasons that are not clear, the sequence of
the Sindbis virus subgenomic promoter can also influ-
ence the host range. One possible explanation may re-
late to the participation of host factors in the assembly of
the RNA synthesizing complex at the promoter for the SG
RNA. In their studies on the evolution of the SG promoter
sequences from nt 213 to nt 29, Hertz and Huang
(1995a) identified within this region (nt 7587–7591 of the
SV genome) three sequences with two, three, or four
changes from the wild-type sequence, which reduced
the yield of virus from mosquito cells much more se-
verely than from BHK cells.
Recently, we reported the selection in mosquito cells
of a mutant Sindbis virus, SVPZF, which is resistant to
pyrazofurin (PZF), a compound that inhibits orotic acid
monophosphate decarboxylase and thus interferes with
the synthesis of UTP and CTP (Lin et al., 2000). Four
mutations, one in the nsP3 and three in the nsP4 coding
region, were identified. The mutation in the nsP3 coding
region changes the opal stop codon to Cys. However,
only the three mutations in the nsP4 coding region wererequired to produce the PZF-resistant phenotype. On the
basis of a molecular model of nsP4, we localized the
N-terminal amino acid change to the fingers domain of
nsP4, i.e., the RNA polymerase, and the other two to the
thumb domain. We suggested that these three amino
acid changes in nsP4 altered the geometry of the NTP
binding pocket, increasing the binding affinity of the
mutant viral RNA polymerase for UTP and CTP and
enabling SVPZF to replicate in cells with low levels of UTP
and CTP.
We now report that, in addition to its PZF-resistant
phenotype, SVPZF has a host range phenotype. Although
it replicates well in mosquito cells (Lin et al., 2000), it is
severely restricted in BHK cells. Only one of the SVPZF
mutations is required to produce the restriction pheno-
type, that at nt 7593. However, this mutation not only
changes Pro 609 of nsP4 to Thr, but also changes the C
at the 25 position of the subgenomic promoter to an A.
Making use of double subgenomic Sindbis viruses, we
showed that both changes were necessary to produce
the strong restriction phenotype.
RESULTS
SVPZF is restricted in BHK cells
Table 1 illustrates the restriction of SVPZF in BHK cells.
The yield of SVPZF from BHK cells was approximately
1000-fold lower than that of standard Sindbis virus
(SVSTD). However, the addition of adenosine (300 mM final
concentration) to the infected BHK cells increased the
yield of SVPZF to a level comparable to that of SVSTD and
thus completely relieved the restriction of SVPZF in BHK
cells. The same concentration of guanosine also in-
creased the yield of SVPZF from BHK cells, but only 10-
fold. Addition of actinomycin D (0.5 mg/ml) had no effect
on either the restriction phenotype of SVPZF or the reliev-
TABLE 1
The Replication of SVPZF Is Restricted in BHK Cells:
Adenosine Relieves the Restriction
SVSTD SVPZF
2Actinomycin D
0.5 mg/ml
No treatment 7.6 3 109 4.7 3 106
300 mM Adenosine 1.6 3 109 1.1 3 109
300 mM Guanosine 9.1 3 109 6.0 3 107
1Actinomycin D
0.5 mg/ml
No treatment 4.6 3 109 3.8 3 106
300 mM Adenosine 4.3 3 109 2.1 3 109
Note. Cells were infected and maintained as described under Ma-
terials and Methods. Actinomycin D, adenosine, and guanosine were
added as indicated. Medium was harvested at 20 h postinfection and
assayed for infectious virus by plaque assay on CEF. This experiment
was done three times. The results in all three experiments were similar.ing effect of adenosine. Adenosine had no effect on the
yield of SVSTD.
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was about 10-fold lower than that of SVSTD. Addition of
adenosine to SVPZF-infected cells abolished this differ-
ence. In CEF no significant restriction was observed.
To help clarify the possible mechanisms whereby
adenosine relieves the restriction of SVPZF in BHK cells,
we measured the levels of ribonucleotides in BHK cells,
which had been treated with 300 mM adenosine or had
been untreated. Figure 1A shows that, by 8 h after treat-
ment, the level of intracellular ATP was increased ap-
proximately three- to fourfold (relative to the zero time or
to untreated cells). There was a small increase in the
level of GTP, the significance of which is uncertain (Fig.
1B). In contrast, the levels of UTP and CTP were de-
creased about five- and twofold, respectively. The reduc-
tions in levels of UTP and CTP following addition of
adenosine to BHK cells recall a similar effect of adeno-
sine on the UTP and CTP pools in mosquito cells (Stollar
and Malinoski, 1981).
To determine at which stage the replication of SVPZF
was restricted in BHK cells, we first examined the syn-
FIG. 1. Effect of adding adenosine to BHK cells on the levels of (A)
ATP and (B) GTP, UTP, and CTP. BHK cells were mock-infected and
treated with adenosine as indicated. Ribonucleotides were extracted at
0, 8, and 16 h and analyzed as described under Materials and Methods.thesis of viral proteins by labeling infected cells with
[35S]methionine. Figure 2 shows that the synthesis of theviral structural proteins was inhibited in the SVPZF-in-
fected BHK cells. The addition of adenosine, however,
increased the synthesis of these viral proteins to a level
similar to that seen in the SVSTD-infected BHK cells.
To determine whether the reduced viral protein syn-
thesis in SVPZF-infected BHK cells was a result of de-
creased synthesis of viral RNA, specifically of the SG
RNA, we compared the synthesis of viral RNA in SVSTD-
and SVPZF-infected cells by labeling cells with
32P-labeled
inorganic phosphate. As seen in Fig. 3, there were sev-
FIG. 2. Viral protein synthesis in BHK cells infected with SVSTD or
SVPZF. Cells were infected and maintained as described under Materi-
als and Methods. Actinomycin D (0.5 mg/ml) was added to all cultures,
and adenosine was added as shown. At 7 h after infection, the medium
was replaced with methionine-free medium, and the cells were labeled
with 35S-labeled protein labeling mix (10 mCi/35-mm plate) from 7 to 9 h
after infection. Lysates corresponding to 0.5 3 106 cells were analyzed
using 10% SDS–PAGE with a stacking gel. The gel was dried and
exposed to X-ray film.
FIG. 3. Viral RNA synthesis in BHK cells infected with SVSTD or SVPZF.
Viral RNA, labeled with [32P]orthophosphate from 3 to 8 h after infection,
was extracted and analyzed as described under Materials and Meth-
ods.
plaque
osine,
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was not greatly reduced, relative to SVSTD-infected cells;
(2) the amount of viral SG RNA made in SVPZF-infected
cells was much less than in the SVSTD-infected cells; and
(3) the SVPZF-infected cells, in contrast to the SVSTD-in-
fected cells, made much less SG RNA than genomic
RNA. When adenosine was added to the SVPZF-infected
cultures, it dramatically increased the synthesis of SG
RNA. Adenosine also increased the synthesis of SG RNA
in SVSTD-infected cells, apparently at the expense of
genomic RNA. Using the Kodak Electrophoresis Docu-
mentation and Analysis System 120 we have evaluated
these data more quantitatively. In the SVSTD-infected cells
in the absence of adenosine, the ratio of SG RNA to
genomic RNA synthesized was 1.6; when adenosine was
added, this ratio increased to 5.3. Thus, in both instances
more SG RNA was made than genomic RNA. In the
SVPZF-infected cells, in the absence of adenosine the
ratio of SG to genomic RNA synthesized was only 0.3, but
when adenosine was added the ratio increased to 2.4.
These results suggest that the restriction of SVPZF in BHK
cells may result from a decreased synthesis of SG RNA.
Localization and identification of the mutation(s)
responsible for restriction of SVPZF in BHK cells
To determine which region of the SVPZF genome is
responsible for its restriction in BHK cells, we examined
FIG. 4. Restriction of chimeric viruses containing various sequence
chimeric viruses shown above and maintained as described under Ma
was harvested at 20 h postinfection and assayed for infectious virus by
of adenosine was at least 100-fold lower than in the presence of adensix different chimeric viruses containing SVPZF cDNA se-
quences in an SVTOTO background (Lin et al., 2000), to seewhich were restricted in BHK cells. Four of the chimeric
viruses were restricted (Fig. 4). These were SVTOTO:PZF:
41-7999, SVTOTO:PZF:2784-7999, SVTOTO:PZF:5262-7999,
and SVTOTO:PZF:7334-7999. In contrast to SVSTD, all four
viruses showed at least a 100-fold or higher increase in
titer when infected BHK cells were treated with adeno-
sine (data not shown). These results indicate that the
SVPZF sequence from nt 7334 to nt 7999 is sufficient to
cause the restriction phenotype. Two of the SVPZF muta-
tions (A7543U, C7593A), which we described previously
(Lin et al., 2000), lie within this region.
In our earlier work (Lin et al., 2000), we had generated
viruses which contained all possible combinations of the
SVPZF mutations in an SVTOTO background. These mutants
were used to determine which of the SVPZF mutations were
required for the restriction phenotype. Since only two of
these mutations, A7543U and C7593A, lie within the nt
7334–7999 region, we expected that either one or both
would suffice to cause the restriction phenotype. For con-
venience we refer to the mutations at nt 5750, 6627, 7543,
and 7593 as mutations 1, 2, 3, and 4, respectively.
Table 2 shows that when mutations 1, 2, 3, or 4 were
introduced one at a time, only mutation 4 produced the
restriction phenotype; when the mutations were intro-
duced as pairs, only 2/4 and 3/4 gave the restriction
phenotype. Interestingly, the 1/4 pair consistently
showed little restriction in BHK cells, suggesting that
d from SVPZF genome. BHK cells were infected (10 PFU/cell) with the
and Methods. Adenosine (500 mM) was added as indicated. Medium
assay on CEF. A plus sign indicates that the viral yield in the absence
i.e., that the virus was restricted in BHK cells.s derive
terialsmutation 1 may in some way diminish the effect of mu-
tation 4.
82 LIN, SIMMONDS, AND STOLLARCombinations of three mutations led to restriction in
BHK cells only if mutation 4 were present. The combina-
tions 1/2/4 and 1/3/4 showed the restriction phenotype
but not to the same degree as the combination 2/3/4. In
these experiments, mutations 1/2/3/4 also showed a
lower degree of restriction than the combination 2/3/4.
From these results, we conclude that the SVPZF muta-
tion 4 alone is sufficient to cause restriction in BHK cells
but that mutations 2 and 3 enhance the restriction. Mu-
tation 1, on the other hand, appears to counteract the
effect of mutation 4.
The restriction of SVPZF in BHK cells requires both the
mutated SG promoter and the amino acid change in
nsP4 at position 609
The coding region for the C-terminus of nsP4 of Sind-
bis virus overlaps with the SG promoter, i.e., the promoter
from which the transcription of SG RNA is initiated
(Strauss et al., 1984). Thus the SVPZF mutation at nt 7593,
which was required and sufficient for the restriction in
BHK cells, not only results in an amino acid change (Pro
TABLE 2
BHK Restriction Phenotypes of Viruses
with Various SVPZF Mutations
Virus
Adenosine (500 mM)
b/a Restriction2 (a) 1 (b)
SVSTD 1.0 3 10
9 6.2 3 108 0.6 2
SVPZF 4.9 3 10
6 5.7 3 108 116 1
SVMut1 9.4 3 10
8 8.7 3 108 0.9 2
SVMut2 3.8 3 10
8 5.8 3 108 1.5 2
SVMut3 6.2 3 10
8 1.3 3 109 2.1 2
SVMut4 2.4 3 10
7 1.4 3 109 58 1
SVMut1,2 3.4 3 10
8 6.8 3 108 2.0 2
SVMut1,3 4.0 3 10
8 8.5 3 108 2.1 2
SVMut1,4 6.1 3 10
8 1.2 3 109 2.0 2
SVMut2,3 1.3 3 10
8 6.8 3 108 5.5 2
SVMut2,4 4.7 3 10
6 2.5 3 108 53 1
SVMut3,4 1.3 3 10
7 6.2 3 108 48 1
SVMut1,2,3 2.1 3 10
8 9.3 3 108 4.4 2
SVMut1,2,4 1.3 3 10
7 6.5 3 108 50 1
SVMut1,3,4 2.1 3 10
7 7.7 3 108 37 1
SVMut2,3,4 2.3 3 10
6 3.5 3 108 152 1
SVMut1,2,3,4 6.2 3 10
6 3.4 3 108 55 1
Note. BHK cells were infected and maintained as described under
Materials and Methods with or without 500 mM adenosine. Medium
was harvested at 20 h postinfection and assayed for infectious virus by
plaque assay on CEF. A plus sign indicates that the virus was re-
stricted. In this experiment, a difference between the virus yield in the
absence and in the presence of adenosine of close to 40-fold or greater
was taken as evidence of restriction. This experiment was done three
times. Similar results were obtained in all three experiments.
a Mutation 1, A5750U; mutation 2, A6627U; mutation 3, A7543U; mu-
tation 4, C7593A.to Thr) at position 609 of nsP4 but also causes a C to A
transversion at the 25 position of the minimal SG pro-moter (Levis et al., 1990). Accordingly, the reduction of
viral SG RNA synthesis in SVPZF-infected BHK cells (Fig.
3) could be mediated by the mutated promoter, the al-
tered RNA polymerase, or an interaction between the
two. To distinguish among these possibilities, we made
use of a double subgenomic Sindbis virus. This virus
was obtained by transfecting cells with RNA transcribed
from the plasmid, pTCS (Hertz and Huang, 1995a,b); see
Fig. 5. In this double SG virus, SVTCS, the SG promoter 1,
as in the normal SV, overlaps with the coding sequence
for the C-terminus of nsP4, but plays no role in the
expression of the viral genes encoding the structural
proteins. SG promoter 2, which is upstream of the genes
for the structural proteins C, E2, and E1, controls the
expression of these genes, but does not overlap with the
nsP4 coding sequence. Thus, with SVTCS, it is possible to
mutate the SG promoter upstream of the genes for the
structural proteins without altering nsP4 and, conversely,
to mutate the nsP4 coding region, i.e., to introduce the
change at residue 609 of nsP4, without altering the SG
promoter from which the RNA encoding the structural
proteins is transcribed.
We therefore introduced SVPZF mutation 4 into SG pro-
moter 1 (thereby changing the amino acid at position 609
of nsP4), into SG promoter 2, or into both promoters of
SVTCS. The three mutagenized double SG viruses were
then tested, along with the parental SVTCS, for the restric-
tion phenotype in BHK cells. SVTCS encodes a wild-type
nsP4 and wild-type SG promoters for SG RNA 1 and RNA
2. SVmSG1 carries the C to A mutation at nt 7593, which
results in a mutant nsP4, as well as a mutant SG pro-
moter 1 for SG RNA 1, but it retains the wild-type pro-
moter for SG RNA 2. SVmSG2 encodes a wild-type nsp4 but
has the SVPZF mutation 4 (C8422A) at the 25 position of
SG promoter 2. SVmSG1SG2 contains mutations in both pro-
moters and therefore generates a mutant form of nsP4,
along with mutations in both SG promoters.
FIG. 5. Linear map of pTCS. The nucleotide numbering begins with
the first base of the SV RNA, followed by the vector sequence. Infec-
tious Sindbis virus containing double subgenomic promoters was gen-
erated by linearizing the plasmids and then transfecting cells with RNA
transcripts of the plasmid.
oth SG
83RESTRICTION OF SV MUTANT IN BHK CELLSTable 3 shows that SVTCS (the double subgenomic virus
without any mutations) replicated well both in the ab-
sence and in the presence of adenosine. In contrast,
SVmSG1SG2 was severely restricted in BHK cells, and just as
is the case with SVPZF, the restriction was relieved by the
addition of adenosine. However, SVmSG1, which encodes
a mutant nsP4 but does not change SG promoter 2,
showed only a modest restriction. A similar low degree
of restriction, again relieved by adenosine, was observed
for SVmSG2, which encodes a wild-type nsP4, but has a
mutant SG promoter 2. As with SVmSG1SG2, the addition of
adenosine (300 mM) increased the yield of both SVmSG1
and SVmSG2. We conclude from these results that the full
restriction phenotype in BHK cells, as displayed by SVPZF,
requires both the amino acid change in nsP4 and the
mutation in SG promoter 2.
We next proceeded to measure the synthesis of viral
RNA and viral proteins in cells infected with the different
double SG viruses. Figure 6 shows that mutation of SG
promoter 2, but not of SG promoter 1, led to decreased
synthesis, relative to SVTCS-infected cells, of all the viral
structural proteins. Mutations in both promoters also
resulted in an inhibition in the synthesis of these pro-
T
Restriction of SV
SVSTD SVPZF
Adenosine 0 mM (a) 3.1 3 109 6.0 3 10
300 mM (b) 4.9 3 109 6.1 3 10
b/a 1.6 102
Note. Cells were infected and maintained as described under Mater
300 mM adenosine as indicated. Medium was harvested at 20 h posti
wild-type SG1 and SG2 promoters. SVmSG1 has a C to A mutation at the 2
of SG promoter 2. SVmSG1SG2 has C to A mutations at the 25 position of b
obtained each time.
FIG. 6. Viral protein synthesis in BHK cells infected with double
subgenomic Sindbis viruses with mutated SG promoters. Cells were
infected with the various double SG viruses as indicated. The proce-
dure was as described for Fig. 2, except that cells were incubated with
methionine-free medium from 8 to 9 h postinfection and then labeled
35with S-labeled protein labeling mix (100 mCi/35-mm plate) from 9 to
10 h after infection.teins. Mutation of SG promoter 1, i.e., changing amino
acid 609 of nsP4, had no effect on the synthesis of the
viral structural proteins. The addition of adenosine (300
mM) increased the synthesis of the viral structural pro-
teins in the SVmSG2- and SVmSG1SG2-infected BHK cells to a
level comparable to that observed in the SVTCS- and
SVmSG1-infected cells. Adenosine also slightly increased
the synthesis of the viral structural proteins in the SVTCS-
and SVmSG1-infected cells. These results clearly indicate
that the amino acid change at position 609 of nsP4 by
itself does not reduce synthesis of the viral structural
proteins.
Next we examined the synthesis of viral SG RNA in
cells infected with the mutated double SG viruses. Figure
7 shows that the synthesis of SG RNA 1 (transcribed from
the SG promoter 1 of SVTCS) was decreased in SVmSG1-
infected cells, that the synthesis of SG RNA 2 (tran-
scribed from the SG promoter 2 of SVTCS) was decreased
in SVmSG2-infected BHK cells, and that the synthesis of
both SG RNA 1 and RNA 2 was decreased in SVmSG1SG2-
infected BHK cells. In each case, the addition of adeno-
sine (300 mM) restored the synthesis of the SG RNA to
dSG Promoters
SVTCS SVmSG1 SVmSG2 SVmSG1SG2
7.0 3 108 9.0 3 107 2.9 3 107 5.0 3 106
5.1 3 109 2.0 3 109 8.0 3 108 1.8 3 109
7.3 22 28 360
d Methods. Cultures were treated with actinomycin D (0.5 mg/ml) and
n and assayed for infectious virus by plaque assay on CEF. SVTCS has
ion of the SG1 promoter. SVmSG2 has a C to A mutation at the 25 position
promoters. This experiment was done four times. Similar results were
FIG. 7. Viral RNA synthesis in BHK cells infected with double sub-
genomic Sindbis viruses with mutated SG promoters. Cells infected
and treated as described under Materials and Methods were incubated
with 32P-labeled orthophosphate (100 mCi/35-mm plate) from 3 to 8 h
after infection. The total RNA was isolated with TriZol reagent, dena-
tured in buffer containing formaldehyde and de-ionized formamide, andABLE 3
with
6
8
ials an
nfectio
5 positthen resolved in 1% formaldehyde–agarose gels. The gel was dried and
exposed to X-ray film.
84 LIN, SIMMONDS, AND STOLLARthe level seen with SVTCS. Thus, as was the case with the
reduced synthesis of the viral structural proteins, the
reduced synthesis of viral SG RNA 2 (the RNA which
encodes the structural proteins) required only the muta-
tion in the promoter for this RNA (SG promoter 2) but not
the alteration in nsP4.
DISCUSSION
The SVPZF mutant has features which make it of special
interest. To our knowledge, it is the only example of a
viral mutant which has been selected on the basis of its
ability to grow in cells with decreased levels of rNTPs.
The demonstration that the host restriction phenotype
can be completely relieved by the addition of adenosine
draws attention to the importance of the rNTP pools in
viral replication. Finally, among the alphaviruses, SVPZF is
the only example so far of a drug-resistance mutation
which maps to nsP4, the viral RDRP.
We isolated SVPZF by selecting for a mutant able to
replicate in PZF-treated mosquito cells. Thus the findings
that SVPZF was severely restricted in BHK cells and that
this phenotype could be relieved by adenosine were
surprising. We assumed initially that the restriction phe-
notype of SVPZF could be explained by its altered RDRP.
We postulated that perhaps the concentrations of UTP
and CTP in BHK cells were too high for the optimal
replication of SVPZF, which we assumed encoded an
RDRP adapted to low levels of these substrates. Accord-
ing to this hypothesis, the addition of adenosine to BHK
cells by reducing the levels of UTP and CTP (Fig. 2B)
would create an intracellular environment more favor-
able for the polymerase encoded by SVPZF. This idea was
also consistent with our observations that when infected
mosquito cells were treated with low concentrations of
PZF or PALA, both of which lower the levels of UTP and
CTP (not shown), the yields of SV were increased up to
10-fold. However, the addition of PZF to BHK cells [PZF
does not inhibit the replication of SVSTD in BHK cells (Lin
et al., 2000)] failed to relieve the restriction of SVPZF.
Furthermore, if the restriction were due to the mutant
RDRP, one would expect that total viral RNA synthesis,
both genomic and subgenomic, would be decreased in
SVPZF-infected BHK cells; our results, however, clearly
show that the restriction phenotype was associated with
a specific defect in the synthesis of SG RNA. Neverthe-
less, the results of experiments with the mutated double
SG viruses showed that although the C7593A mutation at
the 25 position of SG promoter 2 did reduce synthesis of
SG RNA 2, both the P609T change in nsP4 and the
mutation at the 25 position of SG promoter 2 were required
to produce the full restriction phenotype of SVPZF (Table 3).
That a reduction in the yield of Sindbis virus can result
from mutations in the SG promoter and the resultant
decreased synthesis of SG RNA has been convincingly
documented by Hertz and Huang (1995a,b) in their workwith double SG viruses. They noted, in fact, “a direct
correlation between promoter activity and progeny virion
production.” Also noteworthy (in their studies they fo-
cused on the sequence of the SG promoter from posi-
tions 213 to 29) are their observations that deviations
from the wild-type sequence in this region reduced the
yield of progeny virus from mosquito cells much more
drastically than from BHK cells. For example, their C3
virus, which had four changes from the -13 to -9 wild-type
sequence, showed a 25-fold reduction in yield relative to
the control in BHK cells, but a 2000-fold reduction in
mosquito cells. We have not carried out extensive stud-
ies of our mutated double SG viruses in mosquito cells,
but did observe that SVmSG2 replicated very poorly in
mosquito cells. On the other hand, SVTOTO containing only
the C7593A mutation (mutation 4) replicated in mosquito
cells as well as SVPZF.
Turning to the question of how adenosine relieves the
restriction of SVPZF in BHK cells, we propose the following
hypothesis to explain both the defect in SG RNA synthe-
sis and the action of adenosine in reversing this pheno-
type. We suggest that the sequence change in the SG
promoter, together with the amino acid changes in nsP4,
reduces the affinity of the RNA polymerase for the SG
promoter, which results in a destabilization of the RNA
polymerase–promoter initiation complex and a decrease
in the synthesis of SG RNA. Addition of adenosine to BHK
cells dramatically increases the level of ATP (Fig. 1A).
Since ATP is the initiating nucleotide for the synthesis of
SG RNA, and thus part of the initiation complex, the
increased concentration of ATP is able to compensate
for the “destabilization” of the polymerase–promoter com-
plex and subsequent weakening of the SG promoter
activity (which result from the C7593A mutation), thus
allowing the synthesis of normal amounts of SG RNA.
An attractive precedent for this hypothesis comes from
studies on the Escherichia coli ribosomal RNA promoter,
in which Gaal et al. (1997) showed that the sequence of
this promoter influences not only the stability of the
polymerase promoter complex, but also the concentra-
tion of the initiating rNTP required to initiate transcrip-
tion. Thus in in vitro experiments, when a ribosomal RNA
transcript began with an A, transcription was very sen-
sitive to and dependent on the concentration of ATP, as
opposed to the other rNTPs, but when it began with a G,
it was very sensitive to the concentration of GTP. The
presence of base substitutions or a deletion in the pro-
moter sequence dramatically influenced both the stabil-
ity of the polymerase–promoter complexes and the effi-
ciency of transcription. These experiments demonstrated
that the sequence of a promoter can determine the
concentration of the initiating rNTP needed for maximal
efficiency of transcription. We suggest that a similar
situation exists with respect to the SVPZF SG promoter, in
that the transcription initiation complex, with the mutated
SG promoter and altered nsP4, requires an elevated
85RESTRICTION OF SV MUTANT IN BHK CELLSconcentration (above that normally present in the BHK
cells) of the initiating nucleotide, ATP, to function effi-
ciently.
We do note that the double SG virus with the SVPZF 4
mutation only in SG promoter 1 showed a mild restriction
in BHK cells (Table 3) even though it apparently made
normal amounts of SG RNA 2 (Fig. 7) and the viral
structural proteins (Fig. 6). At present, we have no expla-
nation for why this is so.
Experiments are under way to see whether it is pos-
sible to change the initiating nucleotide of the SG tran-
script from an A to a G. If such a change is compatible
with viability, we suggest that a C to A change at the 25
position of the SG promoter will still result in a restriction
phenotype in BHK cells, but that the restriction would
then be relieved most efficiently by addition of
guanosine, rather than adenosine.
MATERIALS AND METHODS
Cells, viruses, and plasmids
Primary cultures of CEF, prepared as described previ-
ously (Stollar et al., 1976), and BHK-21 cells (ATCC
CCL10) were grown in Eagle’s MEM supplemented with
nonessential amino acids, 4 mM glutamine, 5% tryptose
phosphate, and 5% bovine serum.
Our standard Sindbis virus has been described else-
where (Shenk and Stollar, 1973). SVTOTO is the virus de-
rived from the plasmid pToto 1101 (Rice et al., 1987). SVPZF
is a mutant of Sindbis virus resistant to PZF, a cytidine
analogue (Lin et al., 2000). Chimeric Sindbis viruses
containing various sequences derived from the SVPZF
genome and viruses containing various combinations of
the mutations found in SVPZF were described by Lin et al.
(2000).
BHK cells were infected with the indicated viruses at
an m.o.i. of 10 PFU/cell (calculated by using the titers as
determined on CEF) and maintained after infection at
34.5°C in medium containing 0.2% BSA in place of se-
rum. Media from infected cultures were harvested 20 h
after infection and virus yields were measured by plaque
formation on primary cultures of CEF (Shenk et al., 1974).
pTCS (14,473 bp, Fig. 5), which was kindly provided to
us by Henry Huang, is a cDNA clone of Sindbis virus
which contains two wild-type SG promoters. A bacterial
chloramphenicol acetyltransferase cDNA is downstream
of SG promoter 1 and the viral structural genes are
downstream of SG promoter 2 (Hertz and Huang,
1995a,b).
Site-directed mutagenesis
To introduce the C7593A mutation of SVPZF (Lin et al.,
2000) into the SG promoter 1 of pTCS, the SpeI–XhoI
fragment (nt 5262–8317 of pTCS) containing the SG pro-moter 1 was subcloned into pSL1180 (Amersham Phar-
macia Biotech). Site-directed mutagenesis was carried
out using the QuikChange kit purchased from Strat-
agene. After mutagenesis, the presence of the desired
mutation was confirmed by sequencing. The SpeI–XhoI
fragment DNA sequence with the desired mutation was
then exchanged back into pTCS and the presence of the
mutation in pTCS was reconfirmed.
To introduce the C7593A mutation into the SG pro-
moter 2, the XhoI–BssHII (nt 8317–10,639) fragment was
excised from pTCS and site-directed mutagenesis was
performed as described above.
To generate pTCS with mutations in both subgenomic
promoters, the mutated SpeI–XhoI and XhoI–BssHII frag-
ments just described were combined with the 9096-bp
fragment from pTCS, which had been digested with SpeI
and BssHII (nt 5262/nt 10,639 in pTCS), and a three-
fragment ligation was carried out. This gave a mutant
pTCS containing C to A mutations at nt 7593 and 8422,
respectively. The orientations and mutations in both pro-
moters were confirmed by sequencing. DNA manipula-
tions were performed by standard procedures (Sam-
brook et al., 1989).
To generate virus with two SG promoters, wild-type or
mutant pTCS was linearized with SstI (nt 12,588 and
14,387 in pTCS) and infectious RNA transcripts were
generated as described previously (Mi et al., 1989). The
RNA transcripts were transfected into primary cultures of
CEF to generate infectious double SG viruses.
Synthesis of viral RNA and proteins in infected BHK
cells
BHK cell cultures in 35-mm plates were infected with
virus at an m.o.i. of 10 PFU/cell and maintained at 34.5°
in medium containing 0.2% BSA, 0.5 mg actinomycin
D/ml, and 300 mM adenosine as indicated.
To assess synthesis of viral RNA, cells were incubated
with 32P-labeled orthophosphate (100 mCi/35-mm plate)
from 3 to 8 h after infection. The total RNA was isolated
with TriZol reagent (Gibco BRL) and precipitated with
isopropanol. Ten percent of the total RNA was denatured
in buffer containing formaldehyde and de-ionized form-
amide and then resolved in 1% formaldehyde–agarose
gels (Sambrook et al., 1989). The gel was dried and
exposed to X-ray film.
To assess synthesis of viral proteins, at the times
indicated, medium was replaced with methionine-free
medium, and then cells were labeled with 35S-labeled
protein labeling mix (NEN). Proteins in cell lysate corre-
sponding to 0.5 3 106 cells were precipitated with ace-
tone as described previously (Durbin and Stollar, 1984).
The proteins were analyzed using 10% SDS–PAGE with a
stacking gel. The gel was dried and exposed to X-ray
film.
86 LIN, SIMMONDS, AND STOLLARExtraction and assay of ribonucleotides
BHK cells were mock-infected and treated with adeno-
sine as indicated; ribonucleotides were extracted from the
cells as described by Bofill et al. (1995). Briefly, cells from
each 35-mm plate were lysed with 200 ml of 10% trichloro-
acetic acid. The precipitate was removed by centrifugation
for 1 min at 12,000g. The supernatant was back-extracted
with diethyl ether to a pH of 5, and the ribonucleotide
extracts were analyzed by HPLC (Fairbanks et al., 1995).
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